- Arizona-based CBD maker Kushly Industries has agreed to pay a fine for their false marketing claims about their CBD products, along with claims made about THC.
- The total fine ($30,583.14) was calculated by the amount consumers spent on products that were falsely-advertised.
- The settlement money is being refunded to the customers.
Kushly Industries, a Scottsdale, Arizona-based CBD maker, has agreed to pay over $30,000 for false marketing claims they made back in 2019. In their blog post titled “Cannabis Health Benefits For Women,” they claimed that “the THC content of cannabis helps to minimize the endometriosis pain as it activates the production of dopamine in the body.”
Kushly Industries also claimed that their CBD tinctures, softgels, topicals, and edibles could treat a multitude of different conditions, including:
- Multiple sclerosis (MS)
Owner and CEO of Kushly, Cody Alt, was also named in the settlement. The total fine amounted to $30,583.14, which was determined by the total amount of money spent by consumers on the falsely-advertised products. The settlement payment is being refunded to the customers.
Daniel Kaufman, Acting Director of the FTC’s Bureau of Consumer Protection, mentioned in a statement that “This is the seventh case we’ve brought against CBD sellers who should know better than to make unsupported health claims for their products.”
“There may be some benefits of CBD, but there’s no proof that it can treat the serious health conditions in Kushly’s advertising, such as Parkinson’s, multiple sclerosis, or cancer,” he continued.
False advertising in the CBD industry continues to be an issue, which was heightened by the health scare that the pandemic caused in early 2020. Luckily, the agencies responsible for enforcing these marketing laws have been staying on top of things, and CBD knowledge continues to be shared among consumers.